The susceptibility to experimental autoimmune encephalomyelitis is not related to dysferlin-deficiency

References

• Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentatic F, Hamida MB, Bohlega S, Culper EJ, Amato AA, Bossi K, Oeltjen J, Bejaoui K, McKenna-Yasek D, Hosler BA, Schurr E, Arahata K, de-Jong PJ, Brown RH. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998; 20: 31–36
   PubMed Web of Science ®Google Scholar
• Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, Ivanova S, Raffelsberger T, Maerk I, Hoger H, Jung M, Karbasiyan M, Storch M, Lassmann H, Moss JA, Davison K, Harrison R, Bushby KM, Reis A. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet 1999; 23: 141–142
   PubMed Web of Science ®Google Scholar
• Bansal D, Campbell KP. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 2004; 14: 206–213
   PubMed Web of Science ®Google Scholar
• Izzedine H, Brocheriou I, Eymard B, Le Charpentier M, Romero NB, Lenaour G, Bourry E, Deray G. Loss of podocyte dysferlin expression is associated with minimal change nephropathy. Am J Kidney Dis 2006; 48: 143–150
   PubMedGoogle Scholar
• Hochmeister S, Grundtner R, Bauer J, Engelhardt B, Lyck R, Gordon G, Korosec T, Kutzelnigg A, Berger J, Bradl M, Bittner RE, Lassmann H. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol 2006; 65: 855–865
   PubMed Web of Science ®Google Scholar
• De Luna N, Freixas A, Gallano P, Caselles L, Rojas-García R, Paradas C, Nogales G, Dominguez-Perles R, Gonzales-Quereda L, Vílchez JJ, Márquez C, Bautista J, Guerrero A, Salazar JA, Pou A, Illa I, Gallardo E. Dysferlin expression in monocytes: A source of mRNA for mutation analysis. Neuromuscul Disord 2007; 17: 69–76
   PubMedGoogle Scholar
• Feuk-Lagerstedt E, Movitz C, Pellmé S, Dahlgren C, Karlsson A. Lipid raft proteome of the human neutrophil azurophil granule. Proteomics 2007; 7: 194–205
   PubMedGoogle Scholar
• Han R, Bansal D, Miyake K, Muniz VP, Weiss RM, McNeil PL, Campbell KP. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest 2007; 117: 1805–1813
   PubMed Web of Science ®Google Scholar
• Lammerding J, Lee RT. Torn apart: Membrane rupture in muscular dystrophies and associated cardiomyopathies. J Clin Invest 2007; 117: 1749–1752
   PubMedGoogle Scholar
• De Luna N, Gallardo E, Soriano M, Dominguez-Perles R, de la Torre C, Rojas-García R, Garcia-Verdugo JM, Illa I. Absence of dysferlin alters myogenin expression and delays human muscle differentiation ‘in vitro’. J Biol Chem 2006; 281: 17092–17098
   PubMed Web of Science ®Google Scholar
• Wenzel K, Zabojszcza J, Carl M, Taubert S, Lass A, Harris CL, Ho M, Schulz H, Hummel O, Hubner N, Osterziel KJ, Spuler S. Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy. J Immunol 2005; 175: 6219–6225
   PubMed Web of Science ®Google Scholar
• Kasahara H, Itoh M, Sugiyama T, Kido N, Hayashi H, Saito H, Tsukita S, Kato N. Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides. J Clin Invest 1994; 94: 1026–1036
   PubMedGoogle Scholar
• Imahori SC, Vladutiu AO. Autoimmune granulomatous thyroiditis in inbred mice: Resemblance to subacute (de Quervain's) thyroiditis in man. Proc Soc Exp Biol Med 1983; 173: 408–416
   PubMedGoogle Scholar
• Braley-Mullen H, Johnson M, Sharp GC, Kyriakos M. Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell Immunol 1985; 93: 132–143
   PubMed Web of Science ®Google Scholar
• Jones DE, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: A mouse model of primary biliary cirrhosis. Hepatology 1999; 30: 65–70
   PubMedGoogle Scholar
• Satoh J, Sakai K, Endoh M, Koike F, Kunishita T, Namikawa T, Yamamura T, Tabira T. Experimental allergic encephalomyelitis mediated by murine encephalitogenic T cell lines specific for myelin proteolipid apoprotein. J Immunol 1987; 138: 179–184
   PubMed Web of Science ®Google Scholar
• Selva-O'Callaghan A, Labrador-Horrillo M, Gallardo E, Herruzo A, Grau-Junyent JM, Vilardell-Tarres M. Muscle inflammation, autoimmune Addison's disease and sarcoidosis in a patient with dysferlin deficiency. Neuromuscul Disord 2006; 16: 208–209
   PubMed Web of Science ®Google Scholar
• Mix E, Ibrahim S, Pahnke J, Koczan D, Sina C, Böttcher T, Thiesen HJ, Rolfs A. Gene-expression profiling of the early stages of MOG-induced EAE proves EAE-resistance as an active process. J Neuroimmunol 2004; 151: 158–170
   PubMedGoogle Scholar
• Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1993; 153: 4349–4356
   Google Scholar
• Nemoto H, Konno S, Nakazora H, Miura H, Kurihara T. Histological and immunohistological changes of the skeletal muscles in older SJL/J mice. Eur Neurol 2007; 57: 19–25
   PubMedGoogle Scholar
• Turk R, Sterrenburg E, van der Wees CGC, de Meijer DJ, de Menezes RX, Groh S, Campbell KP, Noguchi S, van Ommen GJB, den Dunnen JT, ‘t Hoen PAC. Common pathological mechanisms in mouse models for muscular dystrophies. FASEB J 2006; 20: 127–129
   PubMedGoogle Scholar
• Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Teuscher C. Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol 2000; 157: 637–645
   PubMed Web of Science ®Google Scholar
• Karlsson J, Zhao X, Lonskaya I, Neptin M, Holmdahl R, Andersson A. Novel quantitative trait loci controlling development of experimental autoimmune encephalomyelitis and proportion of lymphocyte subpopulations. J Immunol 2003; 170: 1019–1026
   PubMed Web of Science ®Google Scholar
• Sudweeks JD, Todd JA, Blankenhorn EP, Wardell BB, Woodward SR, Meeker ND, Estes SS, Teuscher C. Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor b-chain gene on mouse chromosome 6. Proc Natl Acad Sci USA 1993; 90: 3700–3704
   PubMedGoogle Scholar